CDKN1C Antikörper (acLys278)
Kurzübersicht für CDKN1C Antikörper (acLys278) (ABIN7182286)
Target
Alle CDKN1C Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- acLys278
-
Verwendungszweck
- Acetyl-CDKN1C (K278) Antibody
-
Kreuzreaktivität
- Maus, Ratte
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from Human p57 around the acetylation site of K278.
-
Isotyp
- IgG
-
-
anti-Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C) antibody
CDKN1C Reaktivität: Human WB, ELISA, FACS, IHC, ICC Wirt: Maus Monoclonal 1F4A9 unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C) antibodyCDKN1C Reaktivität: Human WB, ELISA, FACS, IHC Wirt: Maus Monoclonal 8G5D5 unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C) antibodyCDKN1C Reaktivität: Human IHC (f) Wirt: Kaninchen Monoclonal unconjugated Recombinant Antibody
anti-Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C) (N-Term) antibodyCDKN1C Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C) (AA 1-100) antibodyCDKN1C Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C) (AA 291-343) antibodyCDKN1C Reaktivität: Human, Maus, Ratte ELISA, FACS, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C) (AA 34-64), (N-Term) antibodyCDKN1C Reaktivität: Human, Maus WB, IF Wirt: Kaninchen Polyclonal RB19047 unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C) (pThr310) antibodyCDKN1C Reaktivität: Human WB, IF, ELISA, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C) antibodyCDKN1C Reaktivität: Human IHC (f) Wirt: Maus Monoclonal KP10 unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C) antibodyCDKN1C Reaktivität: Human IF, FACS, IHC (f) Wirt: Maus Monoclonal SPM308 unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- CDKN1C (Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))
-
Andere Bezeichnung
- CDKN1C
-
Hintergrund
- Beckwith Wiedemann syndrome antibody, BWCR antibody, BWS antibody, CDKI antibody, CDKN 1C antibody, CDKN1C antibody, CDN1C_HUMAN antibody, Cyclin dependent kinase inhibitor 1C antibody, Cyclin dependent kinase inhibitor p57 antibody, Cyclin-dependent kinase inhibitor 1C antibody, Cyclin-dependent kinase inhibitor p57 antibody, KIP 2 antibody, KIP2 antibody, p57 antibody, p57 Kip 2 antibody, p57KIP2 antibody, WBS antibody
-
UniProt
- P49918
-
Pathways
- Zellzyklus, Dopaminergic Neurogenesis
Target
-
